The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 493.00
Bid: 490.00
Ask: 491.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.204%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 493.00
VSVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

27 Nov 2012 07:00

RNS Number : 0497S
Cookson Group PLC
27 November 2012
 



 

27 November 2012

Appointment of Finance Director of Alent plc

 

Cookson Group plc ("Cookson") announced on 1 November 2012 that the Performance Materials division is to be demerged to form a new London listed specialty chemicals company, Alent plc ("Alent"). These proposals were approved by the Court Meeting and the General Meeting of Cookson Shareholders on 26 November 2012 and the demerger is expected to become effective on 19 December 2012.

 

Cookson announces today that David Egan will become Finance Director of Alent with effect from 1 January 2013. 

 

Mr Egan is currently the Chief Financial Officer at ESAB, which was the largest division of Charter International plc which was itself acquired by Colfax Corporation in 2012.

 

Prior to joining ESAB in 2008, Mr Egan was Group Financial Controller of Hanson plc based in London, and prior to that Chief Financial Officer, Hanson Asia Pacific based in Singapore. He has extensive international experience of businesses in Europe, including the Russian Federation, Asia, Australasia, and the Americas.

 

Mr Egan is a qualified Certified Practicing Accountant (CPA), Australia and is a dual British and Australian citizen.

 

Peter Hill, Chairman designate of Alent, said:

 

"I look forward to welcoming David, with his wealth of experience in senior and international finance roles, to Alent's board. His appointment completes the line-up of what I believe will be a strong and experienced Board, with the depth and mix of skills to maximise the opportunities for Alent and its shareholders, as a stand-alone company."

 

As previously announced, Mike Butterworth, currently Group Finance Director of Cookson, will act as Interim Finance Director for Alent from listing until 1 January 2013.

 

No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in respect of this appointment.

 

Ends

 

For further information please contact:

 

Shareholder/Analyst Enquiries:

 

Steve Corbett, Chief Executive designate, Alent plc

Mike Butterworth, Interim Finance Director, Alent plc

 

+44 (0)20 7822 0064

Frances Gibbons, Investor Relations Manager, Alent plc

 

+44 (0) 7850 880868

fgibbons@cookson.com

 

Media Enquiries:

 

John Olsen/Ian Payne

MHP Communications

 

+44 (0)20 3128 8100

 

 

About Alent plc:

 

Alent will comprise what is currently the Performance Materials division of Cookson, a leading global supplier of advanced surface treatment plating chemicals and electronics assembly materials.

 

Alent's principal end-market is global electronics production, accounting for approximately three quarters of revenue, with the other quarter represented by the automotive and other industrial markets.

 

Alent will be organised into two business segments:

 

·; Assembly Materials, trading as Alpha and supplying electronic interconnect materials to assemblers of printed circuit boards (PCBs) and the semiconductor packaging industry

 

·; Surface Chemistries, trading as Enthone and supplying specialty electroplating chemicals and services for use in semiconductors and PCB fabrication, as well as corrosion resistant/decorative coatings for various industries, particularly the automotive industry.

 

Alent had net sales value of £418 million and an adjusted trading profit of £96 million in the year ended 31 December 2011. The net sales value was split broadly one third in each of Europe, Asia and the Americas.

 

Alent is present in over 100 countries and has over 2,500 employees and 23 manufacturing sites worldwide. This enables Alent to supply its customers with highly engineered and customised specialty chemicals and materials on a just in time basis from its strategic locations around the world.

 

Alent's Board will comprise:

 

Peter Hill CBE Non-Executive Chairman

Steve Corbett Chief Executive

David Egan Finance Director

Dr Emma FitzGerald Non-Executive

Lars Förberg Non-Executive

Noël Harwerth Non-Executive; Chairman of the Remuneration Committee

Jan Oosterveld Non-Executive

Mark Williamson Non-Executive; Senior Independent Director; Chairman of Audit Committee

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVQLFLLFFLFBX
Date   Source Headline
23rd Apr 20195:28 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:21 pmRNSAnnual Financial Report
19th Mar 20194:35 pmRNSTotal Voting Rights
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
4th Mar 20194:30 pmRNSHolding(s) in Company
1st Mar 20194:42 pmRNSCompletion of the acquisition of CCPI Inc
1st Mar 20194:30 pmRNSChange in Director's Details
28th Feb 20197:01 amRNSAcquisition
28th Feb 20197:00 amRNSResults for the year ended 31 December 2018
22nd Feb 20197:00 amRNSAppointment of Joint Corporate Broker
12th Feb 20199:13 amRNSHolding(s) in Company
17th Dec 20184:35 pmRNSDirector/PDMR Shareholding
14th Dec 20181:00 pmRNSHolding(s) in Company
7th Dec 201812:30 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:11 pmRNSHolding(s) in Company
6th Nov 20187:00 amRNSQ3 2018 Trading Update
28th Sep 20185:35 pmRNSDirector/PDMR Shareholding
18th Sep 20183:06 pmRNSHolding(s) in Company
14th Sep 20183:15 pmRNSTotal Voting Rights
11th Sep 201812:15 pmRNSHolding(s) in Company
26th Jul 20187:00 amRNSHalf Year Results 30 June 2018
25th Jul 20182:00 pmRNSNotification of Change in Director's Details
13th Jul 20182:18 pmRNSHolding(s) in Company
10th Jul 20185:20 pmRNSHolding(s) in Company
3rd Jul 20182:47 pmRNSHolding(s) in Company
3rd Jul 20182:45 pmRNSHolding(s) in Company
13th Jun 201812:56 pmRNSDirector/PDMR Shareholding
10th May 20181:51 pmRNSResult of AGM 2018
10th May 20187:00 amRNSAGM Trading Update
5th Apr 20184:53 pmRNSAnnual Report and Accounts 2017 and Notice of AGM
4th Apr 20185:41 pmRNSDirector/PDMR Shareholding
4th Apr 20185:38 pmRNSDirector/PDMR Shareholding
19th Mar 20185:11 pmRNSHolding(s) in Company
16th Mar 20184:00 pmRNSDirector/PDMR Shareholding
16th Mar 20184:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20184:25 pmRNSTotal Voting Rights
1st Mar 20187:00 amRNSResults for the year ended 31 December 2017
18th Dec 20176:26 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNSCompletion of US Private Placement
8th Dec 20173:30 pmRNSDirector Declaration
6th Dec 20176:24 pmRNSHolding(s) in Company
4th Dec 20171:35 pmRNSPurchase of Shares
14th Nov 20177:00 amRNSThird Quarter 2017 Trading Update
2nd Nov 201710:58 amRNSDirector/PDMR Shareholding
29th Sep 20173:00 pmRNSDirector/PDMR Shareholding
1st Sep 20174:56 pmRNSDirector/PDMR Shareholding
28th Jul 201711:30 amRNSHolding(s) in Company
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.